Close search box Search

Equinox

Equinox International

Meeting consumer demand in a brand new market

Year

2018

Type

NewCo Establishment

Sector

Consumer & Life Sciences

Equinox is a healthcare and consumer business, cultivating medical cannabis in the UK and retailing branded cannabis products, including for flagship brand Mr NICE

Investment Highlights

  • The global cannabis market is forecast to reach over $100 billion by 2030
  • Initially led by North America, legislative initiatives are now passing across Europe and the rest of the world. This provides an opportunity to develop businesses of lasting value in a newly created industry
  • Kingsley cofounded Equinox International in 2018 to address the demand for medical cannabis. Kingsley operates a central role in the business, providing capital, strategic guidance and operational support to the company 
  • Kingsley also founded the "End Our Pain" lobbying campaign, a key driver in the passing of UK cannabis legislation in 2018
  • Equinox operates solely in federally legal markets, with a Home Office Schedule 1 licence to cultivate medical cannabis at scale in the UK. Equinox's retail brand, "Mr NICE" retails CBD and cannabis accessories across multiple outlets, including in multiple Selfridges stores and Equinox's flagship Mr NICE store in Soho
  • In November 2021, Equinox announced its intention to list the medical cultivation side of its business in the UK in 2022, the first listing of a cannabis company on the UK AIM exchange

It's great working with the Kingsley team on Equinox. Their business and political network have proved invaluable in opening-up cannabis markets and also helping me grow the company.

Xan Morgan
Cofounder and CEO


Equinox Press Releases

Equinox International